Error: Could not add to watchlist. X

Trius Therapeutics Inc

+ Watchlist
TSRX:US
Acquired
TSRX:US was acquired by MRK:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.61
Market Cap (USD)
-
Shares Outstanding (m)
48.269
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Trius Therapeutics, Inc. is a biopharmaceutical company. The Company develops antibiotics for life threatening infections.
ADDRESS
6310 Nancy Ridge Drive
Suite 101
San Diego, CA 92121
United States
PHONE
1-858-452-0370
  • John Finn
    Chief Scientific Ofcr/Co-Founder
  • Philippe G Prokocimer
    Chief Medical Officer
  • Karen Joy Shaw
    Senior VP:Biology
Show More